Document Classification

Section Type: RESULTS

Text: After CPB, the vasopressin group had a lower peak norepinephrine dose than the placebo group (4. 6 + / - 2. 5 versus 7. 3 + / - 3. 5 microg/min, p = 0. 03), a shorter period on catecholamines (5 + / - 6 versus 11 + / - 7 hours, p = 0. 03), fewer hypotensive episodes (1 + / - 1 versus 4 + / - 2, p < 0. 01), and a shorter intensive care unit length of stay (1. 2 + / - 0. 4 versus 2. 1 + / - 1. 4 days, p = 0. 03).